Faeth Therapeutics, Inc. (NASDAQ:FTH)
| Market Cap | 440.30M+61.7% |
| Revenue (ttm) | -4.85M |
| Net Income | -195.53M-629.0% |
| EPS | -7.58-564.7% |
| Shares Out | 25.78M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 353,705 |
| Open | 20.00 |
| Previous Close | 20.10 |
| Day's Range | 16.82 - 20.15 |
| 52-Week Range | 7.45 - 42.14 |
| Beta | n/a |
| Analysts | Buy |
| Price Target | 58.50(+242.51%) |
| Earnings Date | Nov 13, 2026 |
No insider has filed an open-market purchase or sale here in the last 90 days, so there is nothing to score yet.
About FTH
Faeth Therapeutics, Inc. is a clinical-stage biotechnology company focused on improving outcomes for cancer patients through multi-node inhibition of critical oncogenic pathways. [28, 70] The company's lead program, PIKTOR, is an investigational all-oral combination therapy targeting the PI3K/AKT/mTOR pathway. [28, 70]
$FTH stock is featured in our Insider Trades datasets.
→ All Stock ListsRecently reported changes in FTH holdings by institutional investors
Latest 0 13F filings · Source: SEC EDGAR
View all institutional owners →Insider Trading
Quarterly net insider trading by FTH's directors and management
Source: SEC EDGAR (Form 4)
Corporate Lobbying
FTH Estimated quarterly lobbying spending
Source: U.S. Senate LDA
U.S. Patents
New FTH patent grants
Source: USPTO Open Data Portal
Government Contracts
Estimated quarterly amount awarded to FTH from public contracts
Source: USAspending.gov
Top ETF Holders
ETFs with the largest estimated holdings in FTH
| ETF | Est. Holding Size |
|---|---|
| VTIVanguard Morningstar Total Stock Market ETF | $21.03M |
| VXFVanguard Extended Market ETF | $6.60M |
| XBIState Street SPDR S&P Biotech ETF | $4.64M |
| SCHASchwab U.S. Small-Cap ETF | $2.06M |
| IWCiShares Micro-Cap ETF | $1.51M |
| ITOTiShares Core S&P Total U.S. Stock Market ETF | $590.94K |
Estimated from each fund’s disclosed top holdings × AUM
FTH Insider Score
Our composite score: insider buying, sector, volume, tone & dilution
Bull Case vs Bear Case
AI-generated from FTH’s recent data — informational, not investment advice
Recent Insider Activity
No Form 4 filings in the last 90 days.